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Background 
Pigmented epithelioid melanocytoma (PEM) represents a group of rare, heavily pigmented melanocytic 
tumors encompassing lesions previously designated as ‘animal-type melanomas’ and ‘epithelioid blue 
nevi’.(1, 2) Despite the association of multiple such tumors in the setting of Carney complex, most cases 
of PEM occur spontaneously as solitary neoplasms in otherwise healthy patients. The typical clinical 
presentation for PEM is a slow-growing deep seated blue or grey nodule, which may clinically resemble 
cellular blue nevi, pigmented cystic, adnexal or other vascular neoplasms, and occasionally 
melanoma.(3) PEM may arise in both children and adults, and has a known propensity to spread to the 
regional lymph nodes.(2, 4) Despite this latter finding in up to 46% of patients, recurrence at the biopsy 
site or spread beyond the lymph node basin is exceptionally uncommon.(2, 5) Although the molecular 
basis for PEM continues to be characterized,  findings to date suggest that this category of melanocytic 
lesions has genetic alterations distinct from those seen in common nevi, dysplastic nevi, spitz nevi and 
melanoma.(5, 6) Herein, we present an in depth clinical, histopathologic and molecular analysis of a 
This article is protected by copyright. All rights reserved.
 3 
case of PEM occurring on the scalp of a young African American girl found to have a novel NTRK3-
SCAPER gene fusion.   
 
Case Report  
A 4 year-old African American female was referred for a 2-month history of an enlarging lesion 
on her right parietal scalp that was reportedly tender with brushing of her hair. On physical examination 
there was a firm but mobile, largely skin-colored subcutaneous nodule measuring 1.5 x 1.5 cm. A small 
focus of dark pigmentation was observed at the center (Figure 1). A 4-mm punch biopsy was obtained 
from the nodule given the unusual clinical presentation.  
Histopathologic analysis revealed deep dermal and subcutaneous nodular aggregations of heavily 
pigmented epithelioid melanocytes, interspersed with melanophages and occasional lymphocytes 
(Figure 2). The melanocytes were fairly uniform in size and shape and demonstrated vesicular nuclei 
with thin nuclear membranes and conspicuous nucleoli.  In some foci, mild-to-moderate nuclear 
pleomorphism and rare mitoses were observed. The neoplastic cells were highlighted by a Melan-A 
immunohistochemical stain and demonstrated a proliferation index (Ki-67) of less than 5%. 
Immunohistochemistry for PRKAR1A demonstrated retained cytoplasmic expression in the lesional 
melanocytes. No pre-existing congenital pattern nevus or junctional component was observed.  
Single nucleotide polymorphism and comparative genomic hybridization (SNP/CGH) microarray 
analysis revealed two distinct segmental abnormalities consisting of chromothripsis involving 
chromosomes 15q (23 copy number gains and 3 losses) and 17q (13 gains). Prior studies and experience 
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have demonstrated that the vast majority of benign melanocytic nevi typically do not harbor any copy 
number changes (rarely, n=1 or 2), whereas melanoma often demonstrates 3 or more segmental 
amplifications or deletions in reproducible loci (7, 8). The two abnormalities detected in this sample 
have not classically been seen in melanoma, and therefore this result was interpreted as “borderline” 
with a relatively low risk of progression (Figure 3).  
Within the amplified regions a breakpoint was identified within the NTRK3 gene with 
amplification of 5’ end and loss of 3’ end, indicating rearrangement and potentially forming a gene 
fusion at this locus. Subsequent analysis by fluorescence in-situ hybridization (FISH) using break apart 
probes and target capture gene fusion analysis by next generation sequencing (NGS) confirmed 
amplification and deletion of the 5’ and 3’ regions, respectively, of NTRK3 and detection of an in frame 
fusion of exon 7 with exon 13 of SCAPER gene at its 3’ region . Subsequent FISH analysis of the 
SCAPER gene also confirmed the array CGH finding of amplification and deletion of the 3’ and 5’ 
regions, respectively (Figure 4 & 5).  The remainder of the tumor was excised with narrow margins, 
revealing identical histopathology (Figure 2). Follow up history and thorough physical evaluation of the 
patient demonstrated no evidence to suggest underlying Carney Complex.    
Discussion 
Limited published molecular data to date provide support for the notion that sporadic PEM may 
be a distinct category of melanocyte neoplasia separate from dysplastic (or Clark’s), congenital, spitz, 
and blue nevi.  In one of the larger studies exploring this issue(5), expression of PRKAR1A was found to 
be lost in 6/11 cases of sporadic PEM with variable alterations in the underlying gene (locus 17q24.2) 
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detected in 3 of those cases (missense, splice cite, and deletion).  Of note, these latter 3 cases were 
‘combined PEM’ with a component of ordinary compound nevus and unsurprisingly also had the more 
common BRAF p.V600E hotspot mutations.(5) Two of the remaining three cases demonstrated loss of 
PRKAR1A expression (but no genetic alterations were detected at this focus) in addition to MAP2K1 in 
frame deletions (locus 15q22). In the 5 cases with preserved PRKAR1A expression, 2 demonstrated 
PRKCA fusions (locus 17q24.2) and 3 demonstrated no genetic aberrations.(5) A second group recently 
found similar alterations in cases of sporadic PEM as they detected PRKCA fusions in 5/16 of their 
analyzed cases(6). One of their cases also demonstrated both a MYO5A- NTRK3 fusion along with a 
point mutation in PrkaR1α.(6) 
In this report we describe a case of sporadic PEM occurring in a pediatric patient, with the 
diagnosis being supported by characteristic clinical and histopathological features. Moreover, the 
absence of characteristic copy number alterations as is usually seen in melanoma on SNP array helped 
better exclude a malignant phenotype.(7, 8) Interestingly, a small number of copy number alterations 
restricted to chromosomes 15q and 17q were detected. This latter finding may provide additional 
support for the notion that at least some cases of PEM are intermediate/borderline melanocytic tumors. 
Very limited data exists on copy number status in the context of PEM, but it is noteworthy that Cohen et 
al 2018(5) failed to detect significant copy number alterations in any of their 11 cases. Interestingly 
many of the genetic loci previously implicated in PEM as described above (PRKAR1A, MAP2K1, and 
PRKCA) are found on either chromosomes 15q or 17q within the areas found to have chromotrypsis in 
this case. This raises the possibility that one or more of these or related genes could have been affected 
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in this case, potentially driving the copy number changes detected on our SNP array analysis. 
Interestingly, PRKAR1A staining was preserved on immunohistochemistry, which argues against a 
deleterious mutation or gene silencing at this locus. 
A novel finding in this case is the detection of an in frame NTRK3-SCAPER fusion.  NTRK3 
fusions (most often with a 5’ partner such as MYO5A or ETV6) have recently been reported to occur in 
the context of some pediatric spitz nevi (especially pigmented nevus of reed variant) and atypical 
spitzoid tumors (9),(10),(11) To our knowledge, this particular fusion combination has not been reported 
previously in PEM or any other melanocytic neoplasm. The functional significance of this inframe 
fusion, which is producing a truncated SCAPER protein is unclear and  may be worthy of future study. 
We can only speculate as to why the NTRK3- SCAPER fusion in this case was associated with PEM-
like morphology as opposed to pigmented spitz nevus-like morphology that has been described in prior 
series. (9-11) In the case of PEM with a MYO5A- NTRK3 fusion reported by Isales et al 2018, it is likely 
that the concomitant PRKAR1A mutation influenced the ultimate morphology. (6) By deduction, one 
could hypothesize that abnormalities in NTRK3 may predispose to dense melanization, but that a second 
alteration in the cAMP signaling pathway (present, but not discovered in this case) is needed to induce 
the more medium-sized epithelioid cell type seen in PEM.  An additional possibility is that the cell of 
origin could possibly have represented a follicular/ or matrical melanocyte in this case (given the deep 
dermal and subcutaneous position of the tumor), whereas classical pigmented spitz nevi more clearly 
originate from the dermo-epidermal junction and have a different milieu.   
 
This article is protected by copyright. All rights reserved.
 7 
Materials and Methods 
Next generation sequencing: 
A multiplex RNA fusion panel (Archer® FusionPlex® Solid Tumor Kit) was run on RNA extracted 
from representative FFPE tumor block. Briefly, this assay is a targeted sequencing assay that uses 
Anchored Multiplex polymerase chain reaction (AMP) to prepare target-enriched cDNA libraries from 
RNA to detect fusions and other mutations in over 50 genes linked to carcinomas, other solid tumors, 
known sarcoma and hematological malignancy-associated fusions using next generation sequencing. 
This technology allows the detection of not only known recurrent fusions but also previously 
unidentified fusions at key breakpoints in target genes. AMP creates target enriched libraries by using a 
combination of unidirectional gene-specific primers and universal adapters to enrich for both known and 
unknown mutations. Adapters that contain both molecular barcode adapters (MBCs) and sample indices 
permit quantitative multiplex data analysis, read deduplication and accurate mutation calling. MBCs 
help in error correction, sample identification, de duplication, and duplicate read binning for confident 
mutation detection.  
Array comparative genomic hybridization: 
Thick sections (10 µM, n =10) were cut from a representative formalin fixed and paraffin embedded 
(FFPE) tissue block and tumor was macrodissected using a hematoxylin and eosin (H&E)-stained slide 
as a guide.  DNA was extracted and purified using the QIAmp DNA FFPE Tissue Kit (Qiagen, 
Dusseldorf, Germany) according to the manufacturer’s protocols.  Extracted DNA was quantified using 
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the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, Carlsbad, CA, USA) following the 
manufacturer’s instructions, and copy number alteration studies were performed using the OncoScan 
FFPE Express 3.0 gene chip probe SNP microarray (Affymetrix, Santa Clara, CA), as described 
previously. (12) Briefly, DNA from each sample (80 ng) was probed with more than 335,000 SNP-
containing molecular inversion probes targeting interrogation sites of 40 base pairs.  Probe fluorescence 
was compared with a reference human genome, yielding information on both copy number changes 
(gains and losses) and allelic frequency/zygosity. Copy number alteration data from each sample were 
analyzed using Nexus Copy Number software version 9.0 (BioDiscovery, El Segundo, CA, USA).  
Diploid correction was performed, when necessary, according to the manufacturer’s instructions.  
Clinical quality control threshold of MAPD < 0.3 was applied.  
 
Fluorescence in situ hybridization: 
Interphase FISH was carried out as described previously(13).  Bacterial artificial chromosomes (BACs) 
were obtained from the BACPAC Resource Center (Oakland, CA, USA), and probes were prepared as 
described. (13)  For detection of gene rearrangement, deletion or amplification, the following probes 
were used:  for NTRK3, RP11-241D10, 5’end and RP11-93B23, 3’end, and for SCAPER, 3’end, RP11-
289H7.  The integrity and correct localization of all probes were verified by hybridization to metaphase 
spreads of normal peripheral lymphocytes. Slides were examined using an ImagingZ1 microscope (Carl 
Zeiss, Oberkochen, Germany). FISH signals were scored manually (X100 oil immersion) in 
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morphologically intact and non-overlapping nuclei by study author NP, and a minimum of 100 cancer 




Figure 1. Clinical. Deep-seated 1.5 x 1.5 cm nodule with eccentric focus of pigmentation on the right 
parietal scalp. 
Figure 2. Histopathology. A) Scanning view demonstrating a circumscribed, pigmented nodular 
aggregation of neoplastic cells in the deep dermis and subcutis [Original Magnification, 20x].  B) Nests 
of heavily-melanized epithelioid melanocytes containing vesicular nuclei with centrally placed nucleoli. 
[Original Magnification, 200x] C) Sclerosis enveloping nests of melanocytes with dense cytoplasmic 
melanin accumulation obscuring nuclear detail [Original Magnification, 200x].   
Figure 3. Chromosomal SNP Array (upper panel: copy number data, lower panel: allelic ratio plot)  
showing gains and losses in chromosomes 15q and gains in chromosome 17q.  
Figure 4. Fluorescence In-Situ Hybridization confirming amplification of the 5’ portion of NKTR3 and 
the presence of a fusion with SCAPER at its 3’ portion. 
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